US Penny Stocks To Consider In November 2024

As the U.S. stock market experiences a rise, with major indexes on track for weekly gains and Bitcoin reaching new all-time highs, investors are exploring diverse opportunities in various segments. Penny stocks, despite being an older term, continue to attract interest due to their potential for value and growth that larger firms might overlook. This article will explore three penny stocks with strong financials that could offer stability and upside potential for investors interested in smaller companies poised for long-term success.

Top 10 Penny Stocks In The United States

Name	Share Price	Market Cap	Financial Health Rating
BAB (OTCPK:BABB)	$0.8368	$5.81M	★★★★★★
Golden Growers Cooperative (OTCPK:GGRO.U)	$4.50	$69.71M	★★★★★★
QuantaSing Group (NasdaqGM:QSG)	$3.08	$143.63M	★★★★★★
Better Choice (NYSEAM:BTTR)	$1.7017	$3.25M	★★★★★★
RLX Technology (NYSE:RLX)	$1.78	$2.31B	★★★★★★
ZTEST Electronics (OTCPK:ZTST.F)	$0.21	$7.6M	★★★★★★
LexinFintech Holdings (NasdaqGS:LX)	$3.30	$547.49M	★★★★★★
Puma Biotechnology (NasdaqGS:PBYI)	$2.90	$139.41M	★★★★★★
Zynerba Pharmaceuticals (NasdaqCM:ZYNE)	$1.30	$65.6M	★★★★★☆
CBAK Energy Technology (NasdaqCM:CBAT)	$0.8694	$76.61M	★★★★★☆

Click here to see the full list of 740 stocks from our US Penny Stocks screener.

We'll examine a selection from our screener results.

Hyperfine (NasdaqGM:HYPR)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Hyperfine, Inc. is a medical device company that provides magnetic resonance imaging (MRI) products in the United States, with a market cap of $65.36 million.

Operations: The company's revenue is primarily generated from its Medical Imaging Systems segment, totaling $13.26 million.

Market Cap: $65.36M

Hyperfine, Inc., with a market cap of US$65.36 million, is navigating the challenging landscape of penny stocks by focusing on its MRI products. Despite being unprofitable and experiencing increased losses over the past five years, Hyperfine's revenue has shown growth, reaching US$10.57 million for the first nine months of 2024 compared to US$8.35 million in 2023. The company remains debt-free and has a cash runway exceeding one year, providing some financial stability amid volatility concerns. However, management's short tenure may pose challenges as they aim for projected annual revenue growth of 21%.

• Click to explore a detailed breakdown of our findings in Hyperfine's financial health report.
• Assess Hyperfine's future earnings estimates with our detailed growth reports.

GSI Technology (NasdaqGS:GSIT)

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: GSI Technology, Inc. designs, develops, and markets semiconductor memory solutions for various sectors including networking, industrial, medical, aerospace, and military across the United States and internationally with a market cap of $69.83 million.

Operations: The company generates revenue of $19.69 million from the design, development, and sale of integrated circuits.

Market Cap: $69.83M

GSI Technology, Inc., with a market cap of US$69.83 million, faces challenges typical of penny stocks, including unprofitability and increasing losses over the past five years. Despite generating US$19.69 million in revenue from semiconductor memory solutions, its negative return on equity and less than one-year cash runway highlight financial vulnerabilities. Recent earnings showed a decline in sales to US$4.55 million for Q2 2025 compared to the previous year, with net losses widening to US$5.46 million. Although debt-free and supported by seasoned management and board members, volatility remains high amid executive changes and modest revenue guidance for upcoming quarters.

• Unlock comprehensive insights into our analysis of GSI Technology stock in this financial health report.
• Gain insights into GSI Technology's historical outcomes by reviewing our past performance report.

Vista Gold (NYSEAM:VGZ)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Vista Gold Corp. is engaged in acquiring, exploring, evaluating, and advancing gold exploration and development projects in Australia, with a market cap of $70.56 million.

Operations: Vista Gold Corp. does not report any revenue segments, focusing instead on gold exploration and development activities in Australia.

Market Cap: $70.56M

Vista Gold Corp., with a market cap of US$70.56 million, is pre-revenue and focuses on gold exploration in Australia. Recent drilling at the Mt Todd project has shown promising high-grade gold intercepts, indicating potential resource expansion. The company remains debt-free and has not significantly diluted shareholders over the past year. Despite being pre-revenue, Vista Gold reported net income of US$12.92 million for the first nine months of 2024, marking a turnaround from previous losses. A recent US$8 million equity offering aims to support ongoing development activities at Mt Todd, positioning it as a significant development opportunity in a strong gold market environment.

• Navigate through the intricacies of Vista Gold with our comprehensive balance sheet health report here.
• Explore historical data to track Vista Gold's performance over time in our past results report.

Next Steps

• Investigate our full lineup of 740 US Penny Stocks right here.
• Have a stake in these businesses? Integrate your holdings into Simply Wall St's portfolio for notifications and detailed stock reports.
• Join a community of smart investors by using Simply Wall St. It's free and delivers expert-level analysis on worldwide markets.

Ready For A Different Approach?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Jump on the AI train with fast growing tech companies forging a new era of innovation.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com